1. vinnabarta@gmail.com : admin :
  2. admin_naim@vinnabarta.net : admin_naim :
Dhaka’s air remains in ‘good’ category with an AQI score of 29 - EN-vinnabarta

Dhaka’s air remains in ‘good’ category with an AQI score of 29

Vinnabarta Desk
  • Update Time : Tuesday, October 11, 2022
  • 69 Time View

This undated UNB photo shows the view of a Dhaka street.

Dhaka’s air quality continued to be in the ‘good’ category on Tuesday morning.

With an air quality index score of 29, the metropolis ranked 70th in the list of world cities with the worst air quality at about 10:00am.

Pakistan’s Karachi and Lahore and North Macedonia’s Skopje occupied the first three spots in the list, with AQI scores of 214, 168, and 144, respectively.

An AQI between 50 and 100 is considered ‘moderate’ with an acceptable air quality. Meanwhile, an AQI between 101 and 200 is considered ‘unhealthy’, particularly for sensitive groups.

Similarly, an AQI between 201 and 300 is said to be ‘poor’, while a reading of 301 to 400 is considered ‘hazardous’, posing serious health risks to residents.

AQI, an index for reporting daily air quality, is used by government agencies to inform people how clean or polluted the air of a certain city is, and what associated health effects might be a concern for them.

In Bangladesh, the AQI is based on five criteria pollutants — Particulate Matter (PM10 and PM2.5), NO2, CO, SO2 and Ozone.

Dhaka has long been grappling with air pollution issues. Its air quality usually turns unhealthy in winter and improves during the monsoon.

Air pollution consistently ranks among the top risk factors for death and disability worldwide. Breathing polluted air has long been recognised as increasing a person’s chances of developing heart disease, chronic respiratory diseases, lung infections and cancer, according to several studies.

According to the World Health Organisation, air pollution kills an estimated seven million people worldwide every year, largely as a result of increased mortality from stroke, heart disease, chronic obstructive pulmonary disease, lung cancer and acute respiratory infections.